Bio-Path Holdings (NASDAQ: BPTH)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Bio-Path Holdings (NASDAQ: BPTH) through any online brokerage.
The latest price target for Bio-Path Holdings (NASDAQ: BPTH) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting BPTH to fall to within 12 months (a possible -4.31% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Bio-Path Holdings (NASDAQ: BPTH) is $4.18 last updated August 12, 2022, 8:00 PM UTC.
The next Bio-Path Holdings (BPTH) dividend date is projected to be Thursday, September 1, 2022.
Bio-Path Holdings’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Bio-Path Holdings.
Bio-Path Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.